Search Results - "Leung, Rainbow Wing Hei"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer by Xie, Yunong, Wu, Haofeng, He, Yimiao, Liu, Linglin, Huang, Ianto Bosheng, Zhou, Lei, Lin, Cheuk-Yin, Leung, Rainbow Wing-Hei, Loh, Jia-Jian, Lee, Terence Kin-Wah, Ding, Jin, Man, Kwan, Ma, Stephanie, Tong, Man

    Published in Cell death & disease (03-02-2024)
    “…Hepatocellular carcinoma (HCC) is an aggressive malignancy without effective therapeutic approaches. Here, we evaluate the tumor-intrinsic mechanisms that…”
    Get full text
    Journal Article
  2. 2

    Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma by Leung, Rainbow Wing Hei, Lee, Terence Kin Wah

    Published in Cancers (07-11-2022)
    “…Hepatocellular carcinoma (HCC) is a major cause of cancer death worldwide due to its high rates of tumor recurrence and metastasis. Aberrant Wnt/β-catenin…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells by Chung, Katherine Po Sin, Leung, Rainbow Wing Hei, Lee, Terence Kin Wah

    Published in Cancers (25-06-2021)
    “…Cancer stem cells (CSCs) within the tumor bulk play crucial roles in tumor initiation, recurrence and therapeutic resistance. In addition to intrinsic…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Abstract 395: Resistance to tyrosine kinase inhibitor confers an immunosuppressive microenvironment and cross-resistance to immunotherapy through AXL/PDPK1 axis in liver cancer by Xie, Yunong, Huang, Bosheng, Yu, Huajian, Loh, Jia-Jian, Leung, Rainbow Wing-Hei, Lee, Terence, Ma, Stephanie, Tong, Man

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract Systemic therapy is the current standard of care for unresectable advanced hepatocellular carcinoma (HCC), the most malignant form of liver cancer…”
    Get full text
    Journal Article
  9. 9

    SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression by Lei, Martina Mang Leng, Leung, Carmen Oi Ning, Lau, Eunice Yuen Ting, Leung, Rainbow Wing Hei, Ma, Victor Wan San, Tong, Man, Lu, Yin Ying, Huang, Chen Yang, Zhu, Qiao Hua, Ng, Irene Oi Lin, Ma, Stephanie, Lee, Terence Kin Wah

    Published in JHEP reports (01-01-2023)
    “…SCY1-like pseudokinase 3 (SCYL3) was identified as a binding partner of ezrin, implicating it in metastasis. However, the clinical relevance and functional…”
    Get full text
    Journal Article